Corvaton

Medicinal product

(Invented) name

Corvaton

Active substance (s)

Molsidominas

Strength

2 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01DX12, Molsidomine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-02-04

Date of renewal

Documents

2253_Corvaton_2mg_tab_N30_PIL.docx

2253_Corvaton_2mg_tab_N30_PZ.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Molsidominas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
116515	102615	1102615	lizdinė plokštelė	N30		Receptinis	LT/L/25/2353/001	Netiekiama	-	2025-09-30	Yes	2025-07-01	2025-09-30	Download

Stadijos

Data	Stadija
2025-02-04	Registruotas